These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 16505482)

  • 1. Chymotrypsin C (caldecrin) stimulates autoactivation of human cationic trypsinogen.
    Nemoda Z; Sahin-Tóth M
    J Biol Chem; 2006 Apr; 281(17):11879-86. PubMed ID: 16505482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Robust autoactivation, chymotrypsin C independence and diminished secretion define a subset of hereditary pancreatitis-associated cationic trypsinogen mutants.
    Geisz A; Hegyi P; Sahin-Tóth M
    FEBS J; 2013 Jun; 280(12):2888-99. PubMed ID: 23601753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoactivation of mouse trypsinogens is regulated by chymotrypsin C via cleavage of the autolysis loop.
    Németh BC; Wartmann T; Halangk W; Sahin-Tóth M
    J Biol Chem; 2013 Aug; 288(33):24049-62. PubMed ID: 23814066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chymotrypsin C (caldecrin) promotes degradation of human cationic trypsin: identity with Rinderknecht's enzyme Y.
    Szmola R; Sahin-Tóth M
    Proc Natl Acad Sci U S A; 2007 Jul; 104(27):11227-32. PubMed ID: 17592142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased activation of hereditary pancreatitis-associated human cationic trypsinogen mutants in presence of chymotrypsin C.
    Szabó A; Sahin-Tóth M
    J Biol Chem; 2012 Jun; 287(24):20701-10. PubMed ID: 22539344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tighter Control by Chymotrypsin C (CTRC) Explains Lack of Association between Human Anionic Trypsinogen and Hereditary Pancreatitis.
    Jancsó Z; Sahin-Tóth M
    J Biol Chem; 2016 Jun; 291(25):12897-905. PubMed ID: 27129265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human cationic trypsinogen. Role of Asn-21 in zymogen activation and implications in hereditary pancreatitis.
    Sahin-Tóth M
    J Biol Chem; 2000 Jul; 275(30):22750-5. PubMed ID: 10801865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The tetra-aspartate motif in the activation peptide of human cationic trypsinogen is essential for autoactivation control but not for enteropeptidase recognition.
    Nemoda Z; Sahin-Tóth M
    J Biol Chem; 2005 Aug; 280(33):29645-52. PubMed ID: 15970597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolutionary expansion of polyaspartate motif in the activation peptide of mouse cationic trypsinogen limits autoactivation and protects against pancreatitis.
    Orekhova A; Németh BC; Jancsó Z; Geisz A; Mosztbacher D; Demcsák A; Sahin-Tóth M
    Am J Physiol Gastrointest Liver Physiol; 2021 Dec; 321(6):G719-G734. PubMed ID: 34643096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zymogen activation confers thermodynamic stability on a key peptide bond and protects human cationic trypsin from degradation.
    Szabó A; Radisky ES; Sahin-Tóth M
    J Biol Chem; 2014 Feb; 289(8):4753-61. PubMed ID: 24403079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limited proteolyses in pancreatic chymotrypsinogens and trypsinogens.
    Rovery M
    Biochimie; 1988 Sep; 70(9):1131-5. PubMed ID: 3147704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between trypsinogen isoforms in genetically determined pancreatitis: mutation E79K in cationic trypsin (PRSS1) causes increased transactivation of anionic trypsinogen (PRSS2).
    Teich N; Le Maréchal C; Kukor Z; Caca K; Witzigmann H; Chen JM; Tóth M; Mössner J; Keim V; Férec C; Sahin-Tóth M
    Hum Mutat; 2004 Jan; 23(1):22-31. PubMed ID: 14695529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human cationic trypsinogen is sulfated on Tyr154.
    Sahin-Tóth M; Kukor Z; Nemoda Z
    FEBS J; 2006 Nov; 273(22):5044-50. PubMed ID: 17087724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenic cellular role of the p.L104P human cationic trypsinogen variant in chronic pancreatitis.
    Balázs A; Hegyi P; Sahin-Tóth M
    Am J Physiol Gastrointest Liver Physiol; 2016 Apr; 310(7):G477-86. PubMed ID: 26822915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human cationic trypsinogen. Purification, characterization, and characteristics of autoactivation.
    Brodrick JW; Largman C; Johnson JH; Geokas MC
    J Biol Chem; 1978 Apr; 253(8):2732-6. PubMed ID: 632297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of chymotrypsin C cleavage specificity in the calcium-binding loop of human cationic trypsinogen.
    Szabó A; Sahin-Tóth M
    FEBS J; 2012 Dec; 279(23):4283-92. PubMed ID: 23035638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human anionic trypsinogen: properties of autocatalytic activation and degradation and implications in pancreatic diseases.
    Kukor Z; Tóth M; Sahin-Tóth M
    Eur J Biochem; 2003 May; 270(9):2047-58. PubMed ID: 12709065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesotrypsin Signature Mutation in a Chymotrypsin C (CTRC) Variant Associated with Chronic Pancreatitis.
    Szabó A; Ludwig M; Hegyi E; Szépeová R; Witt H; Sahin-Tóth M
    J Biol Chem; 2015 Jul; 290(28):17282-92. PubMed ID: 26013824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human cationic trypsinogen. Arg(117) is the reactive site of an inhibitory surface loop that controls spontaneous zymogen activation.
    Kukor Z; Tóth M; Pál G; Sahin-Tóth M
    J Biol Chem; 2002 Feb; 277(8):6111-7. PubMed ID: 11748242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of trypsinogen activation peptides.
    Chen JM; Kukor Z; Le Maréchal C; Tóth M; Tsakiris L; Raguénès O; Férec C; Sahin-Tóth M
    Mol Biol Evol; 2003 Nov; 20(11):1767-77. PubMed ID: 12832630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.